MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
ENDRA Life Sciences P/E Ratio 2011-2026 | NDRA
Annual P/E Ratio ENDRA Life Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.191 | -0.000342 | -0.883 | -0.0811 | -3.11 | -0.845 | -1 | -1.74 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.000342 | -3.11 | -0.982 |
P/E Ratio of other stocks in the Diagnostics research industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-10.3 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-0.479 | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
-0.0317 | $ 1.16 | 3.12 % | $ 1.47 M |  USA |
 |
Brainsway Ltd.
BWAY
|
-37.1 | $ 24.37 | -0.16 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
-7.25 | $ 26.8 | -3.0 % | $ 297 M |  China |
 |
Aspira Women's Health
AWH
|
-1.67 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.76 | - | -61.36 % | $ 2.46 M | USA |
 |
Celcuity
CELC
|
-3.57 | $ 108.23 | 2.31 % | $ 4.27 B | USA |
 |
Biocept
BIOC
|
-0.185 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-233 | - | - | $ 562 M |  Britain |
 |
Check-Cap Ltd.
CHEK
|
-0.172 | - | - | $ 9.42 M | Israel |
 |
Danaher Corporation
DHR
|
41.4 | $ 209.64 | 0.22 % | $ 149 B | USA |
 |
DarioHealth Corp.
DRIO
|
-0.73 | $ 11.26 | - | $ 319 M | Israel |
 |
Chembio Diagnostics
CEMI
|
-0.54 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
-0.00221 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-0.988 | - | - | $ 79.8 M | USA |
 |
Fulgent Genetics
FLGT
|
-10.9 | $ 23.42 | 1.43 % | $ 708 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.485 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-9.08 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-1.29 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-3.07 | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
21.9 | $ 209.3 | -0.11 % | $ 23.2 B | USA |
 |
Castle Biosciences
CSTL
|
38.9 | $ 30.44 | 1.67 % | $ 846 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
39.9 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
-2.74 | $ 17.63 | -8.42 % | $ 948 M | USA |
 |
DermTech
DMTK
|
-0.421 | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
30.5 | $ 72.79 | -0.41 % | $ 28.4 B | USA |
 |
Interpace Biosciences
IDXG
|
0.615 | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-93.8 | $ 103.39 | -0.06 % | $ 19.5 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
27.3 | $ 285.93 | -0.42 % | $ 23.8 B | USA |
 |
Guardant Health
GH
|
-32.3 | $ 95.36 | -0.04 % | $ 12 B | USA |
 |
QIAGEN N.V.
QGEN
|
102 | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
-53.3 | $ 170.5 | 2.67 % | $ 8.45 B | USA |
 |
Heska Corporation
HSKA
|
-42.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.138 | - | -20.0 % | $ 1.06 M | USA |
 |
Myriad Genetics
MYGN
|
-1.12 | $ 4.61 | 4.06 % | $ 427 M | USA |
 |
ICON Public Limited Company
ICLR
|
21 | $ 103.45 | -0.61 % | $ 8.53 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
48.3 | $ 660.2 | 1.69 % | $ 53.1 B | USA |
 |
Illumina
ILMN
|
-13.4 | $ 123.23 | 0.26 % | $ 19.6 B | USA |
 |
Natera
NTRA
|
-9.69 | $ 209.8 | 0.13 % | $ 20.6 B | USA |
 |
IQVIA Holdings
IQV
|
20.8 | $ 163.11 | -1.07 % | $ 28 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.0769 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
32.7 | $ 1 375.3 | -0.28 % | $ 28.3 B |  Schweiz |
 |
Pacific Biosciences of California
PACB
|
-4.61 | $ 1.7 | 2.11 % | $ 431 M | USA |
|
Biodesix
BDSX
|
-2.14 | $ 13.3 | 2.15 % | $ 1.72 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.27 | $ 31.48 | -0.06 % | $ 20 B | Niderland |
 |
Lantheus Holdings
LNTH
|
20.7 | $ 74.86 | 1.7 % | $ 5.18 B | USA |
 |
Quidel Corporation
QDEL
|
13 | $ 23.05 | 5.09 % | $ 971 M | USA |
 |
Biomerica
BMRA
|
-1.45 | $ 2.1 | - | $ 4.82 M | USA |